Zinc-sodium nitroprusside nanomaterial and its preparation method and application

Through the preparation method of zinc-nitroprusside nanomaterials, ultrasonic treatment and hydrogen peroxide stimulation, the problem of instability in the release of NO gas in the prior art was solved, stable release at the wound site was achieved, wound healing effect was improved and the wound was reduced Hazards to normal tissues.

CN118141830BActive Publication Date: 2024-12-06TAIHE HOSPITAL OF SHIYAN CITY (AFFILIATED HOSPITAL OF HUBEI UNIVERSITY OF MEDECINE)
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410259556.6
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-03-07
Publication Date
2024-12-06
Estimated Expiration
2044-03-07

AI Technical Summary

Technical Problem

The prior art is difficult to ensure that nitric oxide (NO) gas is released on demand at wound sites, and traditional methods may result in excessive or too little gas, affecting the therapeutic effect, and causing harm to normal tissues and organs.

Method used

The preparation method of zinc-nitroprusside nanomaterials is adopted to achieve responsive release of NO gas through sonication and hydrogen peroxide stimulation, ensuring stable release of NO at the lesion site.

Benefits of technology

The on-demand release of NO gas is achieved, the treatment effect is improved, the harm to normal tissues and organs is reduced, and effective healing is ensured in the wound area.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118141830B_ABST
    Figure CN118141830B_ABST
Patent Text Reader

Abstract

The invention discloses a zinc-sodium nitroprusside nanomaterial and a preparation method and application thereof, and belongs to the technical field of biomedical materials. The preparation method of the zinc-sodium nitroprusside nanomaterial comprises the following steps: adding a zinc chloride solution dropwise to a first organic phase, and performing a first ultrasonic treatment to obtain a zinc chloride emulsion; adding a sodium nitroprusside solution dropwise to a second organic phase, and performing a second ultrasonic treatment to obtain a nitroprusside emulsion; adding the nitroprusside emulsion dropwise to the zinc chloride emulsion, and performing a light-proof reaction to obtain the zinc-sodium nitroprusside nanomaterial; the first organic phase or the second organic phase is a mixture of cyclohexane and a surfactant. The zinc-sodium nitroprusside nanomaterial proposed by the present invention can release a small amount of NO gas in response to active oxygen, and can also release a large amount of NO gas in response to ultrasound and hydrogen peroxide stimulation.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of biomedical materials, and in particular to a zinc-sodium nitroprusside nanomaterial and a preparation method and application thereof. Background Art

[0002] Skin is the largest organ in the human body, accounting for about 15% of total body weight. It is the first line of defense against physical, chemical and biological factors. In some cases, wounds occur when the integrity of the skin is destroyed and damaged. These include acute trauma caused by mechanical trauma such as war, car accidents, and burns, as well as chronic wounds caused by diabetes, infection and long-term inflammation (wounds that have not healed after 12 weeks). After general injury, the skin can heal itself. This highly coordinated process includes four stages: hemostasis, inflammation, proliferation and remodeling. At present, the healing of complex wounds remains a huge challenge and increases the socioeconomic burden. Clinically, traditional wound treatment mainly uses wound dressings made of gauze, skin grafts and even flap grafts. However, skin grafts have limited donor sites, damaged donors, scar formation, and even severe functional and psychological disorders, and surgery may be challenging. Chronic wounds caused by diabetes, ischemia, excessive collagen degradation and other factors often fail due to their unique wound microenvironment and have a very high mortality rate. In addition, during the occurrence and recovery of wounds, infections often occur, which poses a great threat to the recovery and healing of wounds. Clinically, antibiotics are mainly used to resist bacterial infections. However, excessive use of antibiotics has led to the emergence of drug resistance, resulting in unsatisfactory treatment effects in the later stages. Therefore, it is particularly important to develop new treatment methods for a variety of wounds.

[0003] Nanotechnology is an emerging field that can greatly supplement medical treatment. For example, nanomaterials have a large specific surface area and can be used as drug carriers; they have good biocompatibility, increase blood circulation and reduce biological toxicity; and they have unique properties such as photoelectric, acoustic, magnetic and thermal properties, which can be used for imaging or treatment of diseases.

[0004] Gas therapy is a new type of treatment, which is widely used in tumors, wounds, antibacterial and anti-inflammatory, and neurological diseases. Nitric oxide (NO) is an important type of gas signaling molecule. Its effect on angiogenesis, inflammation, cell proliferation, matrix deposition and remodeling in wound repair may be related to the following aspects: promoting the expression of vascular endothelial growth factor (VEGF), thereby stimulating the proliferation of endothelial cells; stimulating cell migration based on the mechanism of cGMP; inhibiting bacterial proliferation; promoting collagen deposition; promoting angiogenesis; removing reactive oxygen species (ROS), reducing inflammatory factors, and slowing down inflammatory response. The wounds of diabetic patients show a lack of NO, which may be related to the difficulty of their wounds to heal.

[0005] However, there are two problems in gas therapy that have always restricted its development. One is that the determination of the amount of gas has always been a difficult problem to define. If the amount of gas is too much or too little, the release too quickly may not achieve the desired goal, but may have the opposite effect. Another problem is the release of gas. During the treatment of the disease, if the gas can be released at the lesion site in response to internal or external stimuli, it can be released on demand without causing harm to other normal tissues and organs. Although researchers are now working hard to move closer to these two aspects, most gas releases are difficult to achieve now; in addition, the premise for achieving release on demand is to ensure that a large amount of NO is released. How to ensure a large amount of NO is released is also a difficult problem with existing technologies. Summary of the invention

[0006] The purpose of the present invention is to overcome the above technical deficiencies, provide a zinc-sodium nitroprusside nanomaterial and a preparation method and application thereof, and solve the technical problem of how to ensure a larger release amount of NO in the prior art.

[0007] In order to achieve the above technical purpose, the technical solution of the present invention provides a method for preparing a zinc-sodium nitroprusside nanomaterial, comprising the following steps:

[0008] Adding the zinc chloride solution dropwise to the first organic phase, and performing a first ultrasonic treatment to obtain a zinc chloride emulsion;

[0009] adding the sodium nitroprusside solution dropwise to the second organic phase, and performing a second ultrasonic treatment to obtain a nitroprusside emulsion;

[0010] The nitroprusside emulsion is added dropwise to the zinc chloride emulsion to obtain the zinc-sodium nitroprusside nanomaterial by reaction in the dark;

[0011] The first organic phase or the second organic phase is a mixture of cyclohexane and a surfactant.

[0012] In some embodiments, in the first organic phase or the second organic phase, the volume ratio of the cyclohexane to the surfactant is 11:(4-6); and / or the mass ratio of the sodium nitroprusside in the nitroprusside emulsion and the zinc chloride in the zinc chloride solution is 1:(1-1.2).

[0013] In some embodiments, zinc chloride in the zinc chloride solution and cyclohexane in the first organic phase are added dropwise to the first organic phase at a material ratio of 45 mg:(11-12) mL; sodium nitroprusside in the sodium nitroprusside solution and cyclohexane in the second organic phase are added dropwise to the second organic phase at a material ratio of 45 mg:(11-12) mL.

[0014] In some embodiments, the duration of the first ultrasonic treatment or the second ultrasonic treatment is 30-40 min.

[0015] In some embodiments, the surfactant is Leg-520 surfactant.

[0016] In some embodiments, the light-proof reaction time is 12-24 hours.

[0017] In addition, the present invention also provides a zinc-sodium nitroprusside nanomaterial, which is prepared by the above preparation method.

[0018] In addition, the present invention also proposes the zinc-sodium nitroprusside nanomaterial prepared by the above preparation method or the use of the above zinc-sodium nitroprusside nanomaterial in releasing NO.

[0019] In some embodiments, the zinc-sodium nitroprusside nanomaterial is dispersed in H 2 O 2 Incubate in a dark place and then sonicate.

[0020] In some embodiments, the light-proof reaction time is more than 24 hours, and the ultrasound time is more than 5 minutes.

[0021] Compared with the prior art, the beneficial effects of the present invention include: the zinc-sodium nitroprusside nanomaterial proposed in the present invention can release a small amount of NO gas in response to active oxygen, and can also release a large amount of NO gas in response to ultrasound and hydrogen peroxide stimulation, and realizes responsive release of gas, and can realize stable release of NO on demand at the lesion site. BRIEF DESCRIPTION OF THE DRAWINGS

[0022] Figure 1a This is a transmission electron microscope image of the ZFN material prepared in Example 1 of the present invention.

[0023] Figure 1b This is the XRD spectrum of the ZFN material prepared in Example 1 of the present invention.

[0024] Figure 2a This is the result of detecting the removal of active oxygen by the TMB probe of the ZFN material prepared in Example 1 of the present invention.

[0025] Figure 2b This is the release result of 25 ppm NO of the ZFN material prepared in Example 1 of the present invention under different ultrasonic times.

[0026] Figure 2c The figures are the NO release results of the ZFN materials with different concentrations prepared in Example 1 of the present invention under ultrasound for 5 minutes.

[0027] Figure 2d The ZFN material prepared in Example 1 of the present invention at different concentrations in H 2 O 2 The result of NO release under stimulation.

[0028] Figure 2e The ZFN materials of different concentrations prepared in Example 1 of the present invention are 2 O 2 The results of NO release under co-stimulation with ultrasound for 5 minutes.

[0029] Figure 2f The ZFN material prepared in Example 1 of the present invention is 2 O 2 The results of NO release under co-stimulation with different ultrasound times.

[0030] Figure 3 The cell compatibility of the ZFN material prepared in Example 1 of the present invention and the HUVECs cell ROS detection results; wherein, Figure 3 a is 100 μM H 2 O 2 Stimulate the cellular biocompatibility of ZFN materials; Figure 3 b is the cell biocompatibility of ZFN; Figure 3 c is the ROS detection result of HUVECs cells.

[0031] Figure 4 The scratch test and Western Blot test results of the ZFN material prepared in Example 1 of the present invention are shown in FIG. Figure 4 a and 4b are the results of HUMECs scratch assay; Figure 4 c is the result of HUMECs Transwell experiment; Figure 4 d is the result of Western Blot detection of VEGF protein expression. DETAILED DESCRIPTION

[0032] In the present invention, reference is made to “some embodiments”, “this embodiment”, examples, etc., which describe a subset of all possible embodiments, but it can be understood that “some embodiments” may be the same subset or different subsets of all possible embodiments and may be combined with each other without conflict.

[0033] If similar descriptions of "first / second" appear in the application documents, the following instructions are added. In the following description, the terms "first\second\third" involved are merely used to distinguish similar objects and do not represent a specific ordering of the objects. It can be understood that "first\second\third" can be interchanged in a specific order or sequence where permitted, so that the present embodiment described here can be implemented in an order other than that illustrated or described here.

[0034] In this embodiment, the term "and / or" is merely a description of the association relationship between associated objects, indicating that three relationships may exist. For example, object A and / or object B may represent three situations: object A exists alone, object A and object B exist at the same time, and object B exists alone.

[0035] This specific embodiment provides a method for preparing a zinc-sodium nitroprusside nanomaterial, comprising the following steps:

[0036] The zinc chloride solution is added dropwise to the first organic phase, and a first ultrasonic treatment is performed for 30-40 minutes to obtain a zinc chloride emulsion; the zinc chloride in the zinc chloride solution and the cyclohexane in the first organic phase are added dropwise to the first organic phase at a material ratio of 45 mg:(11-12) mL;

[0037] The sodium nitroprusside solution is added dropwise to the second organic phase, and a second ultrasonic treatment is performed for 30-40 min to obtain a nitroprusside emulsion; the sodium nitroprusside in the sodium nitroprusside solution and the cyclohexane in the second organic phase are added dropwise to the second organic phase according to a material ratio of 45 mg:(11-12) mL;

[0038] The nitroprusside emulsion is added dropwise to the zinc chloride emulsion, and the reaction is carried out in the dark for 12-24 hours to obtain the zinc-sodium nitroprusside nanomaterial; the mass ratio of the sodium nitroprusside in the nitroprusside emulsion to the zinc chloride in the zinc chloride solution is 1:(1-1.2);

[0039] The first organic phase or the second organic phase is a mixture of cyclohexane and a surfactant; the volume ratio of the cyclohexane to the surfactant is 11:(4-6); in some embodiments, the surfactant is a Leg-520 surfactant.

[0040] This specific implementation also provides a zinc-sodium nitroprusside nanomaterial, which is prepared by the above preparation method.

[0041] In addition, this specific embodiment also proposes a zinc-sodium nitroprusside nanomaterial prepared by a preparation method or the use of the above zinc-sodium nitroprusside nanomaterial in releasing NO; in some embodiments, the application includes dispersing the zinc-sodium nitroprusside nanomaterial in H 2 O 2 Incubate in dark for more than 24 hours, then sonicate for more than 5 minutes.

[0042] In order to make the purpose, technical solution and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not intended to limit the present invention.

[0043] Example 1

[0044] This embodiment provides a zinc-sodium nitroprusside nanomaterial, which is prepared by the following steps:

[0045] Dissolve 90 mg of zinc chloride in 1 ml of water to obtain a zinc chloride solution, and dissolve 90 mg of sodium nitroprusside in 1 ml of water to obtain a sodium nitroprusside solution, and keep them away from light for later use;

[0046] 8 ml of Leg-520 surfactant was added to 22 ml of cyclohexane and stirred for 30 min, then divided into two equal parts, namely the first organic phase and the second organic phase;

[0047] Adding the zinc chloride solution dropwise to the first organic phase, and performing a first ultrasonic treatment for 30 min to obtain a zinc chloride emulsion;

[0048] The sodium nitroprusside solution is added dropwise to the second organic phase, and a second ultrasonic treatment is performed for 30 min to obtain a nitroprusside emulsion;

[0049] The nitroprusside emulsion was slowly and uniformly added dropwise to the zinc chloride emulsion, and the reaction was carried out overnight in the dark for a total of 20 hours to obtain zinc-sodium nitroprusside nanomaterial, namely ZFN material.

[0050] like Figure 1a As shown in FIG. 1 , the morphology of the zinc-sodium nitroprusside nanomaterials shown by transmission electron microscopy is a uniform sheet-like structure. Figure 1b As shown, the XRD spectrum can be used to determine that this nanomaterial is zinc-sodium nitroprusside nanomaterial.

[0051] Example 2

[0052] This embodiment provides a zinc-sodium nitroprusside nanomaterial, which is prepared by the following steps:

[0053] Dissolve 90 mg of zinc chloride in 1 ml of water to obtain a zinc chloride solution, and dissolve 90 mg of sodium nitroprusside in 1 ml of water to obtain a sodium nitroprusside solution, and keep them away from light for later use;

[0054] 8 ml of Leg-520 surfactant was added to 24 ml of cyclohexane and stirred for 30 min, then divided into two equal parts, namely the first organic phase and the second organic phase;

[0055] Adding the zinc chloride solution dropwise to the first organic phase, and performing a first ultrasonic treatment for 40 min to obtain a zinc chloride emulsion;

[0056] The sodium nitroprusside solution is added dropwise to the second organic phase, and a second ultrasonic treatment is performed for 40 min to obtain a nitroprusside emulsion;

[0057] The nitroprusside emulsion is slowly and uniformly added dropwise to the zinc chloride emulsion, and the reaction is carried out in the dark for 12 hours to obtain zinc-sodium nitroprusside nanomaterial, namely ZFN material.

[0058] Example 3

[0059] This embodiment provides a zinc-sodium nitroprusside nanomaterial, which is prepared by the following steps:

[0060] Dissolve 90 mg of zinc chloride in 1 ml of water to obtain a zinc chloride solution, and dissolve 90 mg of sodium nitroprusside in 1 ml of water to obtain a sodium nitroprusside solution, and keep them away from light for later use;

[0061] 12 ml of Leg-520 surfactant was added to 22 ml of cyclohexane and stirred for 30 min, then divided into two equal parts, namely the first organic phase and the second organic phase;

[0062] Adding the zinc chloride solution dropwise to the first organic phase, and performing a first ultrasonic treatment for 35 minutes to obtain a zinc chloride emulsion;

[0063] The sodium nitroprusside solution was added dropwise to the second organic phase, and a second ultrasonic treatment was performed for 35 min to obtain a nitroprusside emulsion;

[0064] The nitroprusside emulsion was slowly and uniformly added dropwise to the zinc chloride emulsion, and the reaction was carried out in the dark for 18 hours to obtain zinc-sodium nitroprusside nanomaterial, namely ZFN material.

[0065] Example 4

[0066] This embodiment provides a zinc-sodium nitroprusside nanomaterial, which is prepared by the following steps:

[0067] Dissolve 90 mg of zinc chloride in 1 ml of water to obtain a zinc chloride solution, and dissolve 90 mg of sodium nitroprusside in 1 ml of water to obtain a sodium nitroprusside solution, and keep them away from light for later use;

[0068] 10 ml of Leg-520 surfactant was added to 22 ml of cyclohexane and stirred for 30 min, then divided into two equal parts, namely the first organic phase and the second organic phase;

[0069] Adding the zinc chloride solution dropwise to the first organic phase, and performing a first ultrasonic treatment for 30 min to obtain a zinc chloride emulsion;

[0070] The sodium nitroprusside solution is added dropwise to the second organic phase, and a second ultrasonic treatment is performed for 30 min to obtain a nitroprusside emulsion;

[0071] The nitroprusside emulsion is slowly and uniformly added dropwise to the zinc chloride emulsion, and the reaction is carried out in the dark for 24 hours to obtain zinc-sodium nitroprusside nanomaterial, namely ZFN material.

[0072] Application Example 1

[0073] The ZFN used in this application example is the ZFN material of Example 1.

[0074] The ZFN material with a concentration of 25 ppm was added to a 12-well plate, and ultrasonicated for different time periods (0, 5, 10, 20, 30 min) in a light-proof environment. After the ultrasonication, a certain amount of the solution was taken to a 96-well plate, and NO detection reagent was added, and the absorption value was detected by an ELISA instrument;

[0075] Different concentrations of ZFN (0, 12.5, 25, 50, 100, 200 ppm) were added to a 12-well plate and sonicated for 5 min in a light-proof environment. After the reaction, a certain amount of the solution was taken to a 96-well plate, and NO detection reagent was added. The absorbance value was detected by an ELISA instrument;

[0076] Different concentrations of ZFN (0, 12.5, 25, 50, 100, 200 ppm) were dispersed in 100 μM HO. 2 O 2 The reaction was carried out in the dark for 24 hours. After the reaction, a certain amount of solution was taken into a 96-well plate, and NO detection reagent was added. The absorption value was detected by an enzyme reader;

[0077] Different concentrations of ZFN (0, 12.5, 25, 50, 100, 200 ppm) were dispersed in 100 μM HO. 2 O 2 The reaction was carried out in a dark place for 24 hours, and then the reacted material was added to a 12-well plate and ultrasonicated for 5 minutes. After the reaction, a certain amount of solution was taken to a 96-well plate, and NO detection reagent was added, and the absorption value was detected by an enzyme marker.

[0078] ZFN (25 ppm) was dispersed in 100 μM HO 2 O 2 The reaction was carried out in the dark for 24 hours, and ultrasonic treatment was performed for different time periods (0, 5, 10, and 20 min). After the ultrasonic treatment, a certain amount of solution was placed in a 96-well plate, and NO detection reagent was added. The absorption value was detected by an enzyme marker.

[0079] Combination Figure 2a By using the TMB probe to detect the effect of ZFN nanomaterials in scavenging reactive oxygen and reactive nitrogen species (RONS), it was found that ZFN has a good effect in scavenging RONS and is concentration-dependent.

[0080] The release of NO was detected by NO detection kit, combined with Figure 2b , 2c , 2d and 2e found that ultrasound (US) and H 2 O 2 (100 μM) has a good ability to release NO; and NO can be released stably and persistently, providing a good basis for subsequent treatment; while ultrasound or H alone 2 O2 Stimulation, the release of NO is less; combined Figure 2f It can be seen that ultrasound (US) and H 2 O 2 (100 μM) stimulation, the amount of NO released gradually increased with the passage of time, indicating that the amount of NO released is controllable.

[0081] Establishment of cell model

[0082] The cell model was also established using the ZFN material prepared in Example 1.

[0083] The scratch test includes:

[0084] 1. Use 6-well plates, 300,000 cells per well, and grow in an incubator for 24 hours;

[0085] 2. Scratch the cells, wash twice with PBS, photograph under a microscope at 0 hour, add serum-free medium containing different drugs, culture for different time periods, and photograph.

[0086] Transwell experiments include:

[0087] A 24-well plate was used and a transwell chamber was added. 10,000 cells were added to the chamber and serum-free culture medium with different drugs was added. Normal culture medium was added to the well plate. After culturing for different time periods, the plate was washed twice with PBS and fixed with 4% formaldehyde fixative for 15 minutes. Next, the plate was stained with 0.1% crystal violet, washed once with PBS, and carefully wiped with a cotton swab and photographed under a microscope.

[0088] First, we evaluated the toxicity of the prepared ZFN materials using cck-8. Figure 3 As shown in a and 3b, it was found that the ZFN nanosheets had good biocompatibility, and 1.5 ppm could be selected as the subsequent administration concentration. The level of ROS is of great significance for the recovery of the body, so we tested the changes in ROS. By adding 500 μM H 2 O 2 After incubation for 12 h, we established an oxidative stress model of human umbilical vein endothelial cells (HUVECs) to simulate the high ROS environment in the wound. Figure 3 As shown in c, the DCFH-DA probe was used to find that ROS increased significantly after modeling. After the addition of ZFN, the level of ROS decreased significantly, indicating that ZFN has a good ability to clear ROS.

[0089] After a wound occurs, the expression of vascular endothelial growth factor (VEGF) stimulates the proliferation of endothelial cells, thereby forming new blood vessels, a process that is crucial for wound healing. Figure 4As shown in Figures 4a, 4b, and 4c, we found through scratch assays and Transwell assays that ZFN can respond to ROS and release a small amount of NO, thereby promoting the migration of HUMECs. Figure 4 As shown in Figure d, Western Blot revealed that ZFN responded to ROS, produced a small amount of NO, and promoted the expression of VEGF in cells. This indicates that ZFN can release NO in response to reactive oxygen species and promote the migration of endothelial cells, which is expected to further promote wound recovery.

[0090] The specific implementation of the present invention described above does not constitute a limitation on the protection scope of the present invention. Any other corresponding changes and modifications made based on the technical concept of the present invention should be included in the protection scope of the claims of the present invention.

Claims

1. Application of zinc-sodium nitroprusside nanomaterial in the preparation of NO, wherein the zinc-sodium nitroprusside nanomaterial is prepared by the following steps: The zinc chloride solution is added dropwise to the first organic phase, and a first ultrasonic treatment is performed to obtain a zinc chloride emulsion; the sodium nitroprusside solution is added dropwise to the second organic phase, and a second ultrasonic treatment is performed to obtain a nitroprusside emulsion; the nitroprusside emulsion is added dropwise to the zinc chloride emulsion, and the reaction is performed in the dark for 12-24 hours to obtain the zinc-sodium nitroprusside nanomaterial; the first organic phase or the second organic phase is a mixture of cyclohexane and a surfactant; The time of the first ultrasonic treatment or the second ultrasonic treatment is 30-40 min; the surfactant is Leg-520 surfactant; in the first organic phase or the second organic phase, the volume ratio of the cyclohexane to the surfactant is 11:(4-6); the mass ratio of the sodium nitroprusside in the nitroprusside emulsion to the zinc chloride in the zinc chloride solution is 1:(1-1.2); the zinc chloride in the zinc chloride solution and the cyclohexane in the first organic phase are added dropwise to the first organic phase at a material ratio of 45 mg:(11-12) mL; the sodium nitroprusside in the sodium nitroprusside solution and the cyclohexane in the second organic phase are added dropwise to the second organic phase at a material ratio of 45 mg:(11-12) mL; The application of preparing NO also includes: The zinc-sodium nitroprusside nanomaterial is dispersed in H2O2, reacted in the dark, and then sonicated; the reaction time in the dark is more than 24 hours, and the sonication time is more than 5 minutes.